Ampath is proud to be a leading provider of pharmacogenomic testing (PGT) in South Africa. PGT investigates the way an individual’s genetic makeup influences their response to various types of medication. Evidence supporting the clinical benefit of PGT has been growing steadily. Internationally, several professional bodies are now advocating for the implementation of PGT into primary care services. One of the largest published multicentre studies to date demonstrated a 30% reduction in clinically relevant adverse drug reactions using pre-emptive PGT within diverse healthcare settings across seven European countries.... Read more
Evidence for Genotype-guided antiplatelet therapy in patients with coronary artery disease.... Read more